X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4719) 4719
Publication (673) 673
Book Review (20) 20
Book Chapter (12) 12
Conference Proceeding (4) 4
Dissertation (2) 2
Government Document (2) 2
Data Set (1) 1
Newspaper Article (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2754) 2754
animals (2694) 2694
mice (2294) 2294
immunology (2134) 2134
index medicus (1779) 1779
cd40 ligand (1234) 1234
female (1214) 1214
cd40 antigens - metabolism (1089) 1089
male (995) 995
dendritic cells (989) 989
mice, inbred c57bl (951) 951
cd40 antigens - genetics (904) 904
activation (874) 874
cd40 antigens - immunology (858) 858
cells, cultured (841) 841
expression (805) 805
cd40 (786) 786
b-lymphocytes - immunology (781) 781
lymphocytes (685) 685
mice, knockout (677) 677
cd40 antigen (665) 665
dendritic cells - immunology (638) 638
t-cells (627) 627
cd40 ligand - genetics (591) 591
signal transduction (587) 587
t-lymphocytes - immunology (586) 586
mice, inbred balb c (584) 584
flow cytometry (570) 570
in-vivo (563) 563
lymphocyte activation (538) 538
cd40 ligand - metabolism (525) 525
cell biology (485) 485
gene expression (477) 477
ligands (474) 474
cytokines (472) 472
cd40 ligand - immunology (467) 467
t cells (466) 466
apoptosis (463) 463
medicine, research & experimental (458) 458
adult (453) 453
biochemistry & molecular biology (419) 419
antigens (416) 416
inflammation (416) 416
cd4-positive t-lymphocytes - immunology (407) 407
research article (405) 405
hematology (401) 401
oncology (397) 397
research (393) 393
multidisciplinary sciences (390) 390
middle aged (387) 387
b-lymphocytes - metabolism (386) 386
cd40 antigens - physiology (376) 376
cell line (365) 365
antigen (358) 358
medicine (358) 358
proteins (358) 358
molecular sequence data (352) 352
lymphocytes t (346) 346
immunotherapy (345) 345
dendritic cells - metabolism (332) 332
b-cells (330) 330
mice, transgenic (327) 327
nf-kappa-b (327) 327
article (317) 317
membrane glycoproteins - genetics (315) 315
immune system (313) 313
immunity (307) 307
cd8-positive t-lymphocytes - immunology (299) 299
immune response (295) 295
ligand (291) 291
b cells (290) 290
science (289) 289
differentiation (286) 286
induction (286) 286
cell proliferation (284) 284
cancer (283) 283
cell line, tumor (282) 282
lymphocyte activation - immunology (282) 282
transfection (280) 280
base sequence (277) 277
health aspects (277) 277
signal transduction - immunology (275) 275
hemic and immune systems (272) 272
receptor (267) 267
genetic aspects (265) 265
responses (263) 263
analysis (257) 257
cell differentiation (254) 254
nf-kappa b - metabolism (253) 253
immune-responses (246) 246
tumor cells, cultured (244) 244
up-regulation (242) 242
gene expression regulation (239) 239
cd40 antigens - biosynthesis (231) 231
physiological aspects (228) 228
dendritic cells - cytology (225) 225
antigen presentation (220) 220
aged (219) 219
biology (217) 217
mutation (216) 216
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4658) 4658
Chinese (44) 44
Japanese (13) 13
Russian (5) 5
Spanish (4) 4
French (3) 3
Dutch (2) 2
German (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The EMBO Journal, ISSN 0261-4189, 04/2015, Volume 34, Issue 7, pp. 925 - 939
The development and function of B lymphocytes is regulated by numerous signaling pathways, some emanating from the B‐cell antigen receptor (BCR). The spleen... 
BAFF receptor | mb1‐CreERT2 | Syk | B‐cell antigen receptor | CD19 | mb1-CreER T 2 | B-cell antigen receptor | LYN | ACTIVATION | mb1-CreER(T2) | MARGINAL ZONE | BIOCHEMISTRY & MOLECULAR BIOLOGY | PROTEIN-TYROSINE KINASE | PHOSPHOINOSITIDE 3-KINASE | CELL BIOLOGY | RECOMBINASE ACTIVITY | IN-VIVO | DIFFERENTIATION | NF-KAPPA-B | ANTIGEN RECEPTOR | Antigens, CD - immunology | CD40 Antigens - antagonists & inhibitors | Cell Survival - genetics | Intracellular Signaling Peptides and Proteins - immunology | Antigens, CD19 - genetics | Antigens, CD - genetics | Phosphatidylinositol 3-Kinases - immunology | Protein-Tyrosine Kinases - immunology | Signal Transduction - immunology | Protein-Tyrosine Kinases - genetics | ADP-ribosyl Cyclase 1 - immunology | CD40 Antigens - genetics | Interleukin-4 - genetics | Membrane Glycoproteins - immunology | B-Cell Activation Factor Receptor - genetics | Intracellular Signaling Peptides and Proteins - genetics | Syk Kinase | Antigens, CD19 - immunology | B-Cell Activation Factor Receptor - immunology | B-Lymphocytes - cytology | Interleukin-4 - antagonists & inhibitors | ADP-ribosyl Cyclase 1 - genetics | Signal Transduction - genetics | Cell Survival - immunology | Receptors, Antigen, B-Cell - immunology | Membrane Glycoproteins - genetics | Mice, Knockout | Antibodies - pharmacology | Phosphatidylinositol 3-Kinases - genetics | Interleukin-4 - immunology | Animals | B-Lymphocytes - immunology | Lipopolysaccharides - pharmacology | Receptors, Antigen, B-Cell - genetics | Mice | Oligodeoxyribonucleotides - pharmacology | CD40 Antigens - immunology | Lymphocyte receptors | T cell receptors | Kinases | Immune system | mb1-CreERT2
Journal Article
Immunity, ISSN 1074-7613, 06/2015, Volume 42, Issue 6, pp. 1048 - 1061
Journal Article
Journal of Autoimmunity, ISSN 0896-8411, 2009, Volume 32, Issue 3, pp. 231 - 239
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 05/2017, Volume 127, Issue 5, pp. 1651 - 1663
Mature B cell pools retain a substantial proportion of polyreactive and self-reactive clonotypes, suggesting that activation checkpoints exist to reduce the... 
MEDICINE, RESEARCH & EXPERIMENTAL | SYSTEMIC-LUPUS-ERYTHEMATOSUS | INTERFERON-GAMMA | TOLL-LIKE RECEPTOR-9 | MARGINAL ZONE | ESCAPE TOLERANCE | LYMPHOCYTE STIMULATOR | SOMATIC MUTATION | AUTOANTIBODY PRODUCTION | T-CELLS | CUTTING EDGE | Toll-Like Receptor 9 - genetics | Male | T-Box Domain Proteins - immunology | G1 Phase Cell Cycle Checkpoints - immunology | MAP Kinase Signaling System - immunology | Toll-Like Receptor 9 - immunology | Cell Differentiation - genetics | Interleukins - genetics | MAP Kinase Signaling System - genetics | Interleukins - immunology | B-Cell Activating Factor - immunology | Female | CD40 Antigens - genetics | Interferon-gamma - genetics | Cell Line | DNA - immunology | p38 Mitogen-Activated Protein Kinases - genetics | p38 Mitogen-Activated Protein Kinases - immunology | T-Box Domain Proteins - genetics | G1 Phase Cell Cycle Checkpoints - genetics | Receptors, Antigen, B-Cell - immunology | Mice, Knockout | Cell Differentiation - immunology | Animals | B-Lymphocytes - immunology | B-Cell Activating Factor - genetics | Interferon-gamma - immunology | Antigens - immunology | Receptors, Antigen, B-Cell - genetics | Mice | CD40 Antigens - immunology | Antigens | DNA | Cytokine receptors | TLR9 | Cellular signal transduction | Research | B cells | CD27 antigen | CD40 antigen | Laboratories | B-cell receptor | Kinases | Genotype & phenotype | Mitochondria | Cell activation | Lymphocytes | Cell cycle | Interleukin 21 | Toll-like receptors | Deoxyribonucleic acid--DNA | Immunization | Cell survival | Cytokines | Secretion | Cell division | T cell receptors | Survival | TLR9 protein | Immune response (humoral) | Medicine | Lymphocytes B | BLyS protein | Ligands | Interferon | Regulation | Autoimmune diseases | Apoptosis
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 12/2008, Volume 118, Issue 12, pp. 4036 - 4048
infection with influenza A virus (IAV) presents a substantial threat to public health worldwide, with young, elderly, and immunodeficient individuals being... 
MEDICINE, RESEARCH & EXPERIMENTAL | NATURAL-KILLER | IFN-GAMMA PRODUCTION | DENDRITIC CELLS | ALPHA-GALACTOSYLCERAMIDE | IN-VIVO | KILLER T-CELLS | INNATE IMMUNE-RESPONSE | ANTIGEN PRESENTATION | MURINE CYTOMEGALOVIRUS | TUMOR IMMUNOSURVEILLANCE | Influenza A Virus, H1N1 Subtype - immunology | Myeloid Cells - enzymology | Nitric Oxide Synthase - immunology | Influenza, Human - pathology | Antigens, CD1d - immunology | Humans | Arginase - metabolism | Influenza, Human - enzymology | Nitric Oxide Synthase - genetics | Natural Killer T-Cells - enzymology | Arginase - immunology | CD40 Antigens - metabolism | Myeloid Cells - immunology | Natural Killer T-Cells - pathology | Antigens, CD1d - genetics | CD40 Antigens - genetics | Toll-Like Receptors - metabolism | Influenza A Virus, H1N1 Subtype - metabolism | Toll-Like Receptors - immunology | Cells, Cultured | Influenza, Human - epidemiology | Arginase - genetics | Antigens, CD1d - metabolism | Mice, Knockout | Animals | Influenza, Human - genetics | Toll-Like Receptors - genetics | Immune Tolerance - genetics | Mice | Nitric Oxide Synthase - metabolism | Myeloid Cells - pathology | CD40 Antigens - immunology | Influenza, Human - immunology | Natural Killer T-Cells - immunology | Immunosuppression | Influenza | Patient outcomes | Physiological aspects | Research | T cells | Health aspects | Risk factors
Journal Article
Immunological Reviews, ISSN 0105-2896, 11/2011, Volume 244, Issue 1, pp. 115 - 133
Members of the tumor necrosis factor receptor superfamily (TNFRSF) participate prominently in B‐cell maturation and function. In particular, B‐cell activating... 
BAFF | B cell | CD40 | BCMA | NF‐κB | TACI | NF-κB | FORKHEAD TRANSCRIPTION FACTOR | SYSTEMIC-LUPUS-ERYTHEMATOSUS | HUMORAL IMMUNE-RESPONSES | COMMON VARIABLE IMMUNODEFICIENCY | IMMUNOLOGY | KINASE-C-DELTA | GERMINAL CENTER FORMATION | NF-?B | ACTIVATING FACTOR-RECEPTOR | NON-HODGKIN-LYMPHOMA | X-LINKED IMMUNODEFICIENCY | NF-KAPPA-B | Cell Proliferation | Humans | NF-kappa B - immunology | NF-kappa B - metabolism | Transmembrane Activator and CAML Interactor Protein - metabolism | Signal Transduction - immunology | CD40 Antigens - metabolism | B-Cell Activating Factor - immunology | B-Lymphocyte Subsets - immunology | CD40 Antigens - genetics | B-Cell Activation Factor Receptor - genetics | B-Lymphocytes - metabolism | B-Cell Activation Factor Receptor - immunology | B-Cell Maturation Antigen - immunology | Tumor Necrosis Factor Ligand Superfamily Member 13 - immunology | Gene Expression | Mice, Transgenic | Cell Survival - immunology | Immunity, Innate | Tumor Necrosis Factor Ligand Superfamily Member 13 - metabolism | Transmembrane Activator and CAML Interactor Protein - genetics | B-Cell Activation Factor Receptor - metabolism | Animals | B-Cell Activating Factor - metabolism | B-Cell Maturation Antigen - metabolism | B-Lymphocytes - immunology | B-Lymphocyte Subsets - metabolism | NF-kappa B - genetics | B-Cell Activating Factor - genetics | Neoplasms - immunology | Autoimmune Diseases | Tumor Necrosis Factor Ligand Superfamily Member 13 - genetics | Mice | B-Cell Maturation Antigen - genetics | Transmembrane Activator and CAML Interactor Protein - immunology | CD40 Antigens - immunology | Autoimmunity | Antigens | Tumor necrosis factor | Tumors | Necrosis
Journal Article
Molecular Therapy, ISSN 1525-0016, 09/2017, Volume 25, Issue 9, pp. 2176 - 2188
Anti-tumor efficacy of T cells engineered to express chimeric antigen receptors (CARs) is dependent on their specificity, survival, and in vivo expansion... 
CD40 | inducible | costimulation | T cell | chimeric antigen receptor | dimerizer | MyD88 | MEDICINE, RESEARCH & EXPERIMENTAL | EFFECTOR FUNCTIONS | TOLL-LIKE RECEPTOR | ANTITUMOR-ACTIVITY | CUTTING EDGE | THERAPY | MEMORY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | CPG-OLIGODEOXYNUCLEOTIDES | LYMPHODEPLETION | COSTIMULATION | EXPRESSION | Cell Proliferation | Humans | Gene Expression Profiling | Leukemia - metabolism | Recombinant Fusion Proteins | CD28 Antigens - metabolism | Lymphocyte Activation - immunology | CD40 Antigens - metabolism | CD28 Antigens - genetics | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | CD40 Antigens - genetics | Toll-Like Receptors - metabolism | Leukemia - genetics | Disease Models, Animal | Immunotherapy, Adoptive - methods | Receptors, Antigen, T-Cell - metabolism | Signal Transduction | Cell Survival | Leukemia - therapy | Xenograft Model Antitumor Assays | Animals | Leukemia - immunology | Lymphocyte Activation - drug effects | T-Lymphocytes - immunology | Mice | Receptors, Antigen, T-Cell - genetics | Cluster Analysis | Cell proliferation | Antigens | Graft-versus-host reaction | CD40 antigen | Cell survival | Cytokines | CD8 antigen | Cytotoxicity | T cell receptors | Lymphocytes T | Gene expression | Kinases | Adoptive transfer | CD4 antigen | Cell growth | Cell activation | Lymphocytes | Toll-like receptors | MyD88 protein | Tumor necrosis factor-TNF | Ligands | Software | Tumors | Original
Journal Article
Molecular Therapy, ISSN 1525-0016, 07/2017, Volume 25, Issue 7, pp. 1676 - 1685
Targeted approaches to treat autoimmune diseases would improve upon current therapies that broadly suppress the immune system and lead to detrimental side... 
tolerance induction mechanism | antigen-specific tolerance | immune tolerance | PLGA | PLG nanoparticles | MEDICINE, RESEARCH & EXPERIMENTAL | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | DENDRITIC CELLS | ANTIGENS | IL-10 | IMMUNOLOGICAL-TOLERANCE | DELIVERY | RESPONSES | MULTIPLE-SCLEROSIS | PATHWAY | BIOTECHNOLOGY & APPLIED MICROBIOLOGY | GENETICS & HEREDITY | CROSS-PRESENTATION | B7-2 Antigen - genetics | Myelin Proteolipid Protein - immunology | B7-1 Antigen - genetics | Spleen - immunology | Nanoparticles - chemistry | Ovalbumin - immunology | Encephalomyelitis, Autoimmune, Experimental - immunology | Delayed-Action Preparations - chemistry | Spleen - drug effects | Polyglactin 910 - metabolism | T-Lymphocytes, Regulatory - pathology | Delayed-Action Preparations - administration & dosage | Myelin Proteolipid Protein - pharmacology | T-Lymphocytes, Regulatory - immunology | Antigen-Presenting Cells - pathology | Immunoconjugates - pharmacology | Female | CD40 Antigens - genetics | Encephalomyelitis, Autoimmune, Experimental - genetics | Polyglactin 910 - chemistry | B7-2 Antigen - immunology | Myelin Proteolipid Protein - chemistry | Spleen - pathology | Ovalbumin - chemistry | Immune Tolerance - drug effects | Gene Expression | Encephalomyelitis, Autoimmune, Experimental - pathology | B7-1 Antigen - immunology | Immunoconjugates - metabolism | Antigen-Presenting Cells - drug effects | Mice, Inbred C57BL | Ovalbumin - pharmacology | Antigen-Presenting Cells - immunology | Immunoconjugates - chemistry | Antigens - chemistry | Particle Size | Encephalomyelitis, Autoimmune, Experimental - therapy | T-Lymphocytes, Regulatory - drug effects | Animals | Antigens - immunology | Mice | Nanoparticles - administration & dosage | Primary Cell Culture | Antigens - pharmacology | CD40 Antigens - immunology | Cell proliferation | Multiple sclerosis | Transcription factors | CD40 antigen | Disease | Peptides | CD86 antigen | Lymphocytes T | Nanoparticles | Myelin proteolipid protein | Lymphocytes | Localization | Immune system | Antigen presentation | Cytokines | Dendritic cells | Myelin | CD80 antigen | Inflammation | T cell receptors | Immunological tolerance | Studies | Major histocompatibility complex | Antigen-presenting cells | Internalization | PD-L1 protein | Proteolipid protein | Poly(lactide-co-glycolide) | Autoimmune diseases | Apoptosis | Original
Journal Article
The Journal of Immunology, ISSN 0022-1767, 08/2005, Volume 175, Issue 4, pp. 2340 - 2348
ICOS is a new member of the CD28 family of costimulatory molecules that is expressed on activated T cells. Its ligand B7RP-1 is constitutively expressed on B... 
GERMINAL CENTER FORMATION | CXC CHEMOKINE RECEPTOR-5 | OX40 LIGAND | IMMUNE-RESPONSES | ACTIVATION MOLECULE | INDUCIBLE COSTIMULATOR | IMMUNOLOGY | LYMPHOID FOLLICLES | EXPRESSION | MICE LACKING | CUTTING EDGE | Spleen - immunology | Mice, Inbred A | Tumor Necrosis Factor-alpha - genetics | B-Lymphocyte Subsets - cytology | CD28 Antigens - genetics | Mice, Inbred CBA | CD40 Antigens - genetics | CD28 Antigens - physiology | CD40 Antigens - physiology | T-Lymphocytes, Helper-Inducer - metabolism | Membrane Proteins - genetics | Receptors, Cytokine - biosynthesis | Antibodies, Monoclonal - pharmacology | Antigens, Surface - biosynthesis | Spleen - cytology | Mice, Knockout | Cell Differentiation - immunology | Membrane Proteins - biosynthesis | Mice | Mice, Inbred BALB C | Antigens, Differentiation, T-Lymphocyte - biosynthesis | Tumor Necrosis Factor-alpha - biosynthesis | Receptors, CXCR5 | Inducible T-Cell Co-Stimulator Protein | Germinal Center - immunology | Tumor Necrosis Factors | Receptors, OX40 | Tumor Necrosis Factor-alpha - deficiency | Cell Differentiation - genetics | Membrane Proteins - deficiency | Immunization, Secondary | T-Lymphocytes, Helper-Inducer - immunology | Antigens, Differentiation, T-Lymphocyte - physiology | Receptors, Chemokine - biosynthesis | T-Lymphocytes, Helper-Inducer - cytology | B-Lymphocyte Subsets - immunology | Female | Mice, Inbred DBA | Receptors, Tumor Necrosis Factor - deficiency | Membrane Glycoproteins - immunology | Germinal Center - cytology | Receptors, Tumor Necrosis Factor - genetics | B7-1 Antigen - immunology | Mice, Inbred C57BL | Antigens, Surface - genetics | Mice, SCID | Mice, Inbred C3H | Animals | Inducible T-Cell Co-Stimulator Ligand | Spleen - metabolism | Antibodies, Monoclonal - administration & dosage | Antigens, Differentiation, T-Lymphocyte - genetics | Chemokines, CXC - metabolism | Receptors, Tumor Necrosis Factor - biosynthesis
Journal Article